BY AND AMONGStock Purchase Agreement • January 6th, 2003 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • Pennsylvania
1 EX. 10.21.2 [CHOLESTECH LOGO] CHOLESTECH CORPORATION DISTRIBUTION AGREEMENT This Distribution Agreement (this "Agreement") is made and entered into on the day of JUNE 12, 1998 ("Effective Date") by and between BERGEN BRUNSWIG DRUG COMPANY, 4000...Distribution Agreement • November 6th, 1998 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
EXHIBIT 10.60 CHOLESTECH CORPORATION SEVERANCE AGREEMENT This SEVERANCE AGREEMENT (this "Agreement") is made as of February 1, 2005, by and between Cholestech Corporation (the "Company") and Barbara McAleer (the "Executive"). WHEREAS, the Executive is...Severance Agreement • February 2nd, 2005 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
ADDENDUM NO. 2Lease Agreement • June 25th, 2001 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
EXHIBIT 2.1Asset Purchase Agreement • July 7th, 2000 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
EXHIBIT 10.51.1 CHOLESTECH CORPORATION FIRST AMENDMENT TO SEVERANCE AGREEMENT This First Amendment to the Severance Agreement dated as of April 1, 2003 (the "Agreement"), is made as of October 10, 2003 (the "Amendment"), by and between Cholestech...Severance Agreement • February 5th, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
1 2 additional rent shall be payable as and when Operating Costs are payable by Sublessor to Lessor. If the Master Lease provides for the payment by Sublessor of Operating Costs on the basis of an estimate thereof, then as and when adjustments between...Sublease • November 6th, 1998 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
COMPANY CONSULTING AGREEMENT ---------------------------- June 10, 1997 Mark Kussman, VP Sales and Marketing Cholestech Corporation 3347 Investment Blvd, Hayward, CA 94545-3808 ' Dear Mark: Warner-Lambert Company (the "Company") is pleased to offer...Consulting Agreement • November 10th, 1997 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • New Jersey
EXHIBIT 10.30 January 23, 2001 Chief Operating Officer WellCheck, Inc. 331 Jefferson Street Oakland, CA 94607 Dear Chief Operating Officer: Gary M. Reynolds and Associates, Inc., a Wisconsin corporation ("GMR") is pleased to confirm the arrangements...Service Agreement • June 25th, 2001 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • New York
RECITALSChange of Control Severance Agreement • June 8th, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
ANDPreferred Shares Rights Agreement • January 27th, 1997 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
WITNESSETH:Lease Agreement • November 8th, 2001 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
AMENDMENTAmendment • June 25th, 2001 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
1 EXHIBIT 10.17.6 WELLS FARGO BANK REVOLVING LINE OF CREDIT NOTE -------------- ------------------------------------------------------------------Revolving Line of Credit Note • February 4th, 2000 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
July 1, 2001Letter Amendment • November 8th, 2001 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
RECITALSConsent to Sublease Agreement • November 6th, 1998 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
CHOLESTECH CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • October 14th, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of October 12, 2004 (the “Effective Date”), by and between John F. Glenn (the “Employee”) and Cholestech Corporation, a California corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
EXHIBIT 10.58 TRANSITION AGREEMENT This Transition Agreement ("Agreement") is made by and between William Burke ("Executive") and Cholestech Corporation, its predecessors, successors and assigns ("Company") (collectively referred to as the "Parties"):...Transition Agreement • November 3rd, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
EXHIBIT 10.49 TRANSITION AGREEMENT AND RELEASETransition Agreement and Release • June 25th, 2003 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
AGREEMENTChange of Control Severance Agreement • February 2nd, 2005 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
EXHIBIT 10.40 CHOLESTECH CORPORATION AMENDED AND RESTATED SEVERANCE ARRANGEMENT This AMENDED AND RESTATED SEVERANCE ARRANGEMENT (this "Agreement") is made as of June 14, 2001, by and between Cholestech Corporation (the "Company") and the Company's...Severance Arrangement • June 25th, 2003 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG INVERNESS MEDICAL INNOVATIONS, INC., IRIS MERGER SUB, INC. AND CHOLESTECH CORPORATIONAgreement and Plan of Reorganization • June 4th, 2007 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is made and entered into as of June 4, 2007, among Inverness Medical Innovations, Inc., a Delaware corporation (“Parent”), Iris Merger Sub, Inc., a California corporation and a wholly owned first-tier subsidiary of Parent (“Merger Sub”), and Cholestech Corporation, a California corporation (the “Company”).
AMENDMENT TO CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • August 2nd, 2007 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Amendment to the Change of Control Severance Agreement (the “Amendment”) is made as of [ ], 2007, by and between Cholestech Corporation, a California corporation (the “Company”), and [NAME OF EXECUTIVE OFFICER] (the “Employee”).
OEM AGREEMENTOem Agreement • February 1st, 2006 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
This Agreement is made between BOULE Diagnostics International AB, having registration number 556535-0252 (hereafter called the “Company”) with principal offices at Västberga Allé 32, Box 42056, 126 13 STOCKHOLM, Sweden, of the one part and CHOLESTECH Corporation, with principal offices at 3347 Investment Boulevard, HAYWARD, California 94545 USA (hereafter called the ”OEM”) of the other part, and takes effect as of November 14, 2005 (the “Effective Date”).
AMENDMENT TO SEVERANCE AGREEMENTSeverance Agreement • August 2nd, 2007 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Amendment to the Severance Agreement (the “Amendment”) is made as of [ ], 2007, by and between Cholestech Corporation, a California corporation (the “Company”), and [NAME OF EXECUTIVE OFFICER] (the “Employee”).
CHOLESTECH CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • December 12th, 2005 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of December 7, 2005 (the “Effective Date”), by and between Gregory Bennett (the “Employee”) and Cholestech Corporation, a California corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
CHOLESTECH CORPORATION SEVERANCE AGREEMENTSeverance Agreement • December 12th, 2005 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This SEVERANCE AGREEMENT (this “Agreement”) is made as of December 7, 2005, by and between Cholestech Corporation (the “Company”) and Gregory Bennett (the “Executive”).
September 1, 2005 Cholestech Corporation 3347 Investment Blvd. Hayward, CA 94545 Dear Mr. Pinckert:Letter Amendment • February 1st, 2006 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
This letter amendment (this “Amendment”) is to confirm the changes agreed upon between WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”) and CHOLESTECH CORPORATION (“Borrower”) to the terms and conditions of that certain letter agreement between Bank and Borrower dated as of May 1, 2000, as amended from time to time (the “Agreement”). For valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Bank and Borrower hereby agree that the Agreement shall be amended as follows to reflect said changes.
EXHIBIT 10.3.2Standard Industrial/Multi-Tenant Lease • June 26th, 1997 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
AMENDMENT TO AMENDED AND RESTATED PREFERRED SHARE RIGHTS AGREEMENTPreferred Share Rights Agreement • January 25th, 2007 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Amendment to Amended and Restated Preferred Share Rights Agreement (this “Amendment”) is entered into as of this 19th day of January, 2007 by and between Cholestech Corporation, a California corporation (the “Company”), and Computershare Investor Services, LLC (the “Rights Agent”).
1 EXHIBIT 10.17.5 WELLS FARGO BANK REVOLVING LINE OF CREDIT NOTE -------------- ------------------------------------------------------------------Revolving Line of Credit Note • February 8th, 1999 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
WELLS FARGO BANK REVOLVING LINE OF CREDIT NOTE -------------------------------------------------------------------------------Revolving Line of Credit Note • February 10th, 1997 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
CHOLESTECH CORPORATION SEVERANCE AGREEMENTSeverance Agreement • October 14th, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This SEVERANCE AGREEMENT (this “Agreement”) is made as of October 12, 2004, by and between Cholestech Corporation (the “Company”) and John F. Glenn (the “Executive”).
LEASE AGREEMENT ADDENDUM NO. ONELease Agreement Addendum • November 23rd, 2004 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus
WHEREAS, BIV Group, a California general partnership (“Lessor” or “Landlord”) and Cholestech Corporation, a California corporation (“Lessee” or “Tenant”) entered into a written Lease Agreement on or about July 23, 2001, for an industrial building containing approximately 68,816 square feet situated at and commonly known as 3233 Investment Boulevard, in Hayward, California, 94545-3808; and
TRANSITION AGREEMENT AND RELEASE RECITALSTransition Agreement and Release • August 3rd, 2005 • Cholestech Corporation • Electromedical & electrotherapeutic apparatus • California
This Transition Agreement and Release (“Agreement”) is made by and between Thomas E. Worthy (“Executive”) and Cholestech Corporation, its predecessors, successors and assigns (“Company”) (collectively referred to as the “Parties”):
